Nano-X Imaging Ltd. (NNOX) is a Health Care company in the X-Ray Apparatus & Tubes & Related Irradiation Apparatus industry (SEC CIK 0001795251). Annual revenue was $0.01B in FY2025, compared to $0.00B in FY2021. Net income in FY2025 was $-0.08B (diluted EPS $-1.16).
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0.01B | $0.01B | $0.01B | $0.01B | $0.00B |
| Gross Profit | $-0.01B | $-0.01B | $-0.01B | $-0.01B | $-0.00B |
| Operating Income | $-0.08B | $-0.06B | $-0.06B | $-0.12B | $-0.06B |
| Net Income | $-0.08B | $-0.05B | $-0.06B | $-0.11B | $-0.06B |
| EPS (Diluted) | $-1.16 | $-0.91 | $-1.08 | $-2.17 | $-1.28 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.16B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-0.04B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | -98.2% | -94.0% |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 20-F | 0001213900-26-050191 | Dec 31, 2025 | Apr 30, 2026 | Apr 30, 2026 20:03 UTC | EDGAR |
| 20-F | 0001213900-25-030318 | Dec 31, 2024 | Apr 9, 2025 | Apr 9, 2025 20:29 UTC | EDGAR |
| 20-F | 0001213900-24-034697 | Dec 31, 2023 | Apr 22, 2024 | Apr 22, 2024 13:23 UTC | EDGAR |
| 20-F | 0001213900-23-034133 | Dec 31, 2022 | May 1, 2023 | May 1, 2023 10:37 UTC | EDGAR |
| 20-F | 0001213900-22-022912 | Dec 31, 2021 | May 2, 2022 | May 2, 2022 12:14 UTC | EDGAR |
| 20-F | 0001213900-21-020392 | Dec 31, 2020 | Apr 6, 2021 | Apr 6, 2021 20:05 UTC | EDGAR |
Direct links to SEC EDGAR. NNOX has additional filings available on the SEC site.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $0.21B |
| $0.22B |
| $0.25B |
| $0.36B |
| Total Liabilities | $0.02B | $0.02B | $0.02B | $0.04B | $0.07B |
|---|
| Stockholders' Equity | $0.14B | $0.19B | $0.00B | $0.22B | $0.29B |
|---|
| Cash & Equivalents | $0.05B | $0.04B | $0.06B | $0.04B | $0.07B |
|---|
| Total Debt | — | — | — | — | — |
|---|
| $-0.04B |
| $-0.04B |
| $-0.04B |
| $-0.04B |
| Capital Expenditures | $0.00B | $0.00B | $0.00B | $0.01B | $0.02B |
|---|
| Free Cash Flow | $-0.04B | $-0.04B | $-0.05B | $-0.05B | $-0.06B |
|---|
| -66.6% |
| -80.2% |
| -116.0% |
| Operating Margin | -4.6% | -5.1% | -6.3% | -1372.2% | -4720.7% |
|---|
| Net Margin | -4.5% | -5.1% | -6.3% | -1320.2% | -4739.1% |
|---|
| Return on Equity | -53.7% | -28.3% | -4051.7% | -52.3% | -21.2% |
|---|
| Return on Assets | -46.3% | -25.5% | -27.8% | -44.6% | -17.0% |
|---|
| Debt / Equity | 0.16× | 0.11× | 0.12× | 0.17× | 0.24× |
|---|
